Cargando…

Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma

OBJECTIVES: Hepatocellular carcinoma (HCC) is a leading cancer-related cause of death. Unfortunately, recurrence is common even after curative treatment of early-stage patients, and no adjuvant treatment has yet been established. Aberrant expression of OLFM4 in human cancers has been reported; yet,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Liangtao, Kriegl, Lydia, Reiter, Florian P., Munker, Stefan M., Itzel, Timo, Teufel, Andreas, Ziesch, Andreas, Török, Helga Paula, Kirchner, Thomas, Gerbes, Alexander L., Guba, Markus, Mayerle, Julia, De Toni, Enrico N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056049/
https://www.ncbi.nlm.nih.gov/pubmed/31990698
http://dx.doi.org/10.14309/ctg.0000000000000124
_version_ 1783503455448465408
author Ye, Liangtao
Kriegl, Lydia
Reiter, Florian P.
Munker, Stefan M.
Itzel, Timo
Teufel, Andreas
Ziesch, Andreas
Török, Helga Paula
Kirchner, Thomas
Gerbes, Alexander L.
Guba, Markus
Mayerle, Julia
De Toni, Enrico N.
author_facet Ye, Liangtao
Kriegl, Lydia
Reiter, Florian P.
Munker, Stefan M.
Itzel, Timo
Teufel, Andreas
Ziesch, Andreas
Török, Helga Paula
Kirchner, Thomas
Gerbes, Alexander L.
Guba, Markus
Mayerle, Julia
De Toni, Enrico N.
author_sort Ye, Liangtao
collection PubMed
description OBJECTIVES: Hepatocellular carcinoma (HCC) is a leading cancer-related cause of death. Unfortunately, recurrence is common even after curative treatment of early-stage patients, and no adjuvant treatment has yet been established. Aberrant expression of OLFM4 in human cancers has been reported; yet, its specific function during tumor development remains poorly understood, and its role in HCC is unknown. The purpose of this study is to examine the prognostic significance of OLFM4 and its functional relevance in determining recurrence in patients with early-stage HCC. METHODS: Immunohistochemical staining to assess expression, cellular distribution, and prognostic significance of OLFM4 was performed in a tissue microarray comprising 157 HCC tissues and matched nontumor tissues. In addition, expression of OLFM4-coding mRNA was assessed in a separate patients' cohort. The findings were validated by in vitro functional studies using siRNA directed against OLFM4 to assess its effect on cell motility and proliferation. RESULTS: The fraction of HCC samples exhibiting positive OLFM4 staining was higher in comparison with that observed in hepatocytes from matched nontumor tissue (61% vs 39%). However, cytoplasmic-only staining for OLFM4 was associated with vascular invasion (P = 0.048), MMP-7 expression (P = 0.002), and poorer survival (P = 0.008). A multivariate analysis confirmed the independent significance of OLFM4 in determining patients' outcome (5-year survival [58.3% vs 17.3%; HR: 2.135 {95% confidence interval: 1.135–4.015}; P = 0.019]). Correspondingly, inhibition of OLFM4 by siRNA modulated the expression of MMP-7 and E-cadherin, causing inhibition of cell proliferation, motility, and migration. DISCUSSION: To the best of our knowledge, we provide the first report on the prognostic significance of OLFM4 in HCC and identify its mechanistic role as crucial mediator of MMP family protein and E-Cadherin in determining cell invasion and metastasis formation.
format Online
Article
Text
id pubmed-7056049
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-70560492020-03-18 Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma Ye, Liangtao Kriegl, Lydia Reiter, Florian P. Munker, Stefan M. Itzel, Timo Teufel, Andreas Ziesch, Andreas Török, Helga Paula Kirchner, Thomas Gerbes, Alexander L. Guba, Markus Mayerle, Julia De Toni, Enrico N. Clin Transl Gastroenterol Article OBJECTIVES: Hepatocellular carcinoma (HCC) is a leading cancer-related cause of death. Unfortunately, recurrence is common even after curative treatment of early-stage patients, and no adjuvant treatment has yet been established. Aberrant expression of OLFM4 in human cancers has been reported; yet, its specific function during tumor development remains poorly understood, and its role in HCC is unknown. The purpose of this study is to examine the prognostic significance of OLFM4 and its functional relevance in determining recurrence in patients with early-stage HCC. METHODS: Immunohistochemical staining to assess expression, cellular distribution, and prognostic significance of OLFM4 was performed in a tissue microarray comprising 157 HCC tissues and matched nontumor tissues. In addition, expression of OLFM4-coding mRNA was assessed in a separate patients' cohort. The findings were validated by in vitro functional studies using siRNA directed against OLFM4 to assess its effect on cell motility and proliferation. RESULTS: The fraction of HCC samples exhibiting positive OLFM4 staining was higher in comparison with that observed in hepatocytes from matched nontumor tissue (61% vs 39%). However, cytoplasmic-only staining for OLFM4 was associated with vascular invasion (P = 0.048), MMP-7 expression (P = 0.002), and poorer survival (P = 0.008). A multivariate analysis confirmed the independent significance of OLFM4 in determining patients' outcome (5-year survival [58.3% vs 17.3%; HR: 2.135 {95% confidence interval: 1.135–4.015}; P = 0.019]). Correspondingly, inhibition of OLFM4 by siRNA modulated the expression of MMP-7 and E-cadherin, causing inhibition of cell proliferation, motility, and migration. DISCUSSION: To the best of our knowledge, we provide the first report on the prognostic significance of OLFM4 in HCC and identify its mechanistic role as crucial mediator of MMP family protein and E-Cadherin in determining cell invasion and metastasis formation. Wolters Kluwer 2020-01-28 /pmc/articles/PMC7056049/ /pubmed/31990698 http://dx.doi.org/10.14309/ctg.0000000000000124 Text en © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Article
Ye, Liangtao
Kriegl, Lydia
Reiter, Florian P.
Munker, Stefan M.
Itzel, Timo
Teufel, Andreas
Ziesch, Andreas
Török, Helga Paula
Kirchner, Thomas
Gerbes, Alexander L.
Guba, Markus
Mayerle, Julia
De Toni, Enrico N.
Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma
title Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma
title_full Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma
title_fullStr Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma
title_full_unstemmed Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma
title_short Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma
title_sort prognostic significance and functional relevance of olfactomedin 4 in early-stage hepatocellular carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056049/
https://www.ncbi.nlm.nih.gov/pubmed/31990698
http://dx.doi.org/10.14309/ctg.0000000000000124
work_keys_str_mv AT yeliangtao prognosticsignificanceandfunctionalrelevanceofolfactomedin4inearlystagehepatocellularcarcinoma
AT kriegllydia prognosticsignificanceandfunctionalrelevanceofolfactomedin4inearlystagehepatocellularcarcinoma
AT reiterflorianp prognosticsignificanceandfunctionalrelevanceofolfactomedin4inearlystagehepatocellularcarcinoma
AT munkerstefanm prognosticsignificanceandfunctionalrelevanceofolfactomedin4inearlystagehepatocellularcarcinoma
AT itzeltimo prognosticsignificanceandfunctionalrelevanceofolfactomedin4inearlystagehepatocellularcarcinoma
AT teufelandreas prognosticsignificanceandfunctionalrelevanceofolfactomedin4inearlystagehepatocellularcarcinoma
AT zieschandreas prognosticsignificanceandfunctionalrelevanceofolfactomedin4inearlystagehepatocellularcarcinoma
AT torokhelgapaula prognosticsignificanceandfunctionalrelevanceofolfactomedin4inearlystagehepatocellularcarcinoma
AT kirchnerthomas prognosticsignificanceandfunctionalrelevanceofolfactomedin4inearlystagehepatocellularcarcinoma
AT gerbesalexanderl prognosticsignificanceandfunctionalrelevanceofolfactomedin4inearlystagehepatocellularcarcinoma
AT gubamarkus prognosticsignificanceandfunctionalrelevanceofolfactomedin4inearlystagehepatocellularcarcinoma
AT mayerlejulia prognosticsignificanceandfunctionalrelevanceofolfactomedin4inearlystagehepatocellularcarcinoma
AT detonienricon prognosticsignificanceandfunctionalrelevanceofolfactomedin4inearlystagehepatocellularcarcinoma